Androgen replacement therapy in the form of either dehydroepiandrosterone or testosterone is becoming increasingly widespread for the treatment of FAI. Evidence exists for the benefits of such therapy in relieving both the physical and psychological symptoms thought to be due to FAI in clinically ...
Monitoring cardiovascular health in men with prostate cancer treated with androgen deprivation therapy Earlier diagnosis and improved treatments have resulted in men with prostate cancer living for many years following diagnosis. Long-term effects of treatme... CA Allan,VR Collins,F Mark,... 被引量...
Clomiphene citrate 25 mg daily may be added to testosterone replacement therapy to help maintain FSH levels and sperm counts.[9][11]This medication will not effectively raise testosterone levels in men with primary hypogonadism (testicular failure), identified by elevated LH levels in hypogonadal men...
A leading proponent of this therapy was Reiter, a German physician.47 Only in the last few years has sufficient scientific evidence been accumulated to begin to satisfy the medical establishment that testosterone levels decline with age and that testosterone replacement therapy may play a role in ...
Because of its role as a prohormone in the biosynthesis of steroid hormones, it has been proposed as a hormone replacement therapy. Suggestions are that DHEA may yield benefits mediated by oestrogen, including improvements in vasomotor symptoms, and testosterone, including increased libido and well...
EnglishEspañolDeutschFrançaisItalianoالعربية中文简体PolskiPortuguêsNederlandsNorskΕλληνικήРусскийTürkçeאנגלית 9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook ...
9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook androgen deprivation therapy Acronyms The use of a gonadotropin-releasing hormone (GnRH) antagonist to treat prostate cancer, which causes characteristic histologic findings that may obscure the diagnosis of residual ca...
Conclusions and Relevance Androgen deprivation therapy in the treatment of prostate cancer may be associated with an increased risk of dementia. This finding should be further evaluated in prospective studies. Introduction Worldwide there are approximately 1.1 million new diagnoses of prostate cancer each...
therapy only disease) did not present data onSREs.20,63,64Based on these trials, intermittent ADT is notinferior in the nonmetastatic rising PSA state and could be considered to limit theadverse effectsof ADT including BMD loss. However, intermittent ADT may reduceoverall survivalin patients ...
Cancer Epidemiol Biomarkers Prev 17: 895 – 901 Bardia A, Stearns V (2010) Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy. Breast Cancer Res Treat 120: 437 – 439 Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T (2003) ...